Advertisement
Biolytix, one of the leading CRO's for molecular biological analysis inSwitzerland has acquired a complete Affymetrix GeneChip(R) instrument systemto enhance the range of services offered. Besides standard gene expressionanalysis services, with this state-of-the-art equipment Biolytix is ready tooffer services using the latest generation GeneChip(R) products. Theseinclude Exon and Tiling arrays as well as SNP genotyping and gene mappingarrays with potential applications in transcriptome mapping, the analysis ofgene regulation as well as genome wide SNP mapping and re-sequencing usingstandard and custom arrays.
Advertisement
The appointment of Biolytix as an Affymetrix authorized service providerfurther enhances the strong reputation of the company in the molecularbiology service provider community. Current and future customers of Biolytixworldwide have now access to the offerings of Affymetrix via the servicesprovided by the company.
Biolytix AG, specialized in molecular and microbiological analyses, wasfounded in 1998 and is situated in Witterswil (Switzerland), 12 km south-westof Basel. The team and its scope of activities have been expandingcontinuously. Biolytix, accredited according to ISO/IEC 17025, offers a widerange of services, the major ambition being to fulfil the customers'expectations through confidential and responsible cooperation. The fields ofactivity of Biolytix are widely distributed in the pharmaceutical, food andcosmetic industry as well as in the veterinarian, agricultural and humandiagnostics.For further information please contact: Adrian Harri, CEO, [email protected], Biolytix AG, Benkenstrasse 254, CH-4108 Witterswil, Switzerland, Tel. +41(0)61-7252070, Fax. +41(0)61-7252071
SOURCE Biolytix AG
